Floatz logo

Human Secretin

Chronic Pancreatitis

ChiRhoClin, Inc.Phase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Chronic Pancreatitis cohort.

Asset / SponsorPhaseRating
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Johns Hopkins University
Phase 3BB
Pancrelipase
Changhai Hospital
Phase 4BB
Triamcinalone
Centre hospitalier de l'Université de Montréal (CHUM)
Phase 3BB
Pregabalin
Asian Institute of Gastroenterology, India
Phase 2/3B
Pioglitazone
University of Michigan
Phase 2B

View all 22 →

Same molecule, other indications

Human Secretin is also rated in:

Intraductal Papillary Mucinous NeoplasmsDormant
CC
Indicative ·
42 / 100
View asset →
pancreatic neoplasmDormant
C
Indicative ·
37 / 100
View asset →
malignant pancreatic neoplasmDormant
C
Indicative ·
36 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →